Tumor markers in the diagnosis of pancreas cancer;I marcatori tumorali nella diagnosi del carcinoma pancreatico

Tumori

Volumn 85, Issue 1 SUPPL. 1, 1999, Pages

  Cappelli, Gino ^a   Paladini, Sergio ^a   D'Agata, Alberino ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

CA 125; CA 19 9; CEA; Pancreatic cancer; Tumoral markers

Indexed keywords

CA 125 ANTIGEN; CA 15-3 ANTIGEN; CA 195 ANTIGEN;

ABDOMINAL PAIN; CANCER STAGING; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; JAUNDICE; PANCREAS CARCINOMA; WEIGHT REDUCTION;

ANTIGENS, NEOPLASM; CA-19-9 ANTIGEN; HUMANS; MUCINS; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0032929589     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Cappelli G. Mathematical model application to the kinetic study of tumor markers. Int. J. Biol. Markers, 9: 8-14, 1994.
2. Cappelli G., D'Agata A., Cefalà L.: CA 19-9, CA 50 and CA 195 are the same mucine like antigen. J. Nucl. Biol. Med., 36: 95-96, 1992.
3. Herlyn M., Steplewski Z., Herlyn D., Koprowski H.: Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc. Nat. Acad. Sci., 76: 1438-1442, 1979.
4. Inokuma T., Tamaki N., Torizuka T., Fujita T., Magata Y., Yonekura Y, Ohshio G., Imamura M., Konishi J.: Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer. J. Nucl. Med., 36: 229-235, 1995.
5. Lamerz R., Dati E, Feller A.C., Shnorr G.: Carboidrato antigene 50 in diagnostica delle neoplasie: i marker del tumori maligni, pp. 92-93, I quaderni de "Il Ponte", Milano, 1990.
6. Klapdor R.: Cancer of the pancreas in tumor markers in clinical oncology: an overview, pp. 33-50, Sorin Biomedica, Saluggia (VC), 1994.
7. Product Information. Centocor CA 19-9 RIA, pp. 10-12, 1992.
8. Willett C.G., Daly W.J., Warshaw A.L.: CA 19-9 is an index of response to neoadjunctive chemotherapy in pancreatic cancer. Am. J. Surg., 172: 350-352, 1996.
9. Yiannakou J.Y., Newland P., Calder R, Kingsnorth A.N., Rhodes J.M.. Prospective study of CAM 17.1/WGA mucin assay for serological diagnosis of pancreatic cancer. Lancet, 349: 389-392, 1997.